ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 154 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2024. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $60,919 | -90.3% | 13,448 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $628,707 | -33.4% | 97,323 | -22.3% | 0.00% | -40.0% |
| Q1 2023 | $944,340 | -54.9% | 125,244 | -36.2% | 0.01% | -54.5% |
| Q2 2022 | $2,092,000 | +65.2% | 196,406 | +51.2% | 0.01% | +57.1% |
| Q1 2022 | $1,266,000 | -67.0% | 129,882 | -25.5% | 0.01% | -74.1% |
| Q2 2021 | $3,837,000 | – | 174,428 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |